Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012072 · ClinicalTrials.gov registry record · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
A NA study of Preterm Birth and Mental Health Wellness 1, sponsored by Microgen.
- Recruiting
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT05012072: Recruiting NA study of Preterm Birth and Mental Health Wellness 1, sponsored by Microgen.
NCT05012072 is a NA study of Preterm Birth and Mental Health Wellness 1 that is actively recruiting participants, run by Microgen. The registered enrollment target is 238 participants, below the 4,403-participant average among 39 other Preterm Birth trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012072, a NA study of Preterm Birth and Mental Health Wellness 1, is actively recruiting participants, sponsored by Microgen.
- RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial will test an intervention called the Mastery Lifestyle Intervention (the MLI) that was developed from data of 1000+pregnant Hispanic women related to risks of preterm birth. The investigators will deliver a psychoeducational intervention that is manualized over 6 group sessions. The investigators will also have a usual care group that receives standard prenatal care. The investigators plan to enroll 238 pregnant women and start the study with them at 14-20 weeks gestation. The investigators will also test the biological response of the intervention by measuring Corticotropin Releasing Hormone, progesterone, estriol, and test for cotinine. The investigators will also determine any effect on infant outcomes at delivery.
Primary Outcome
Self Report questionnaire GAD-7
Conditions Studied
Interventions
- BEHAVIORAL The Mastery Lifestyle Intervention
Study Locations (1)
Texas
- Women's Specialist of PLLC - Webster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2026-04-13 |
| Phase | NA |
What NCT05012072 shows while recruiting
NCT05012072 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 4,403-participant average among 39 other Preterm Birth trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which The Mastery Lifestyle Intervention is the first listed.
NCT05012072 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05012072 about?
NCT05012072 is a clinical study titled "Reducing Pregnancy Risks: The Mastery Lifestyle Intervention". This randomized controlled trial will test an intervention called the Mastery Lifestyle Intervention (the MLI) that was developed from data of 1000+pregnant Hispanic women related to risks of preterm birth. The investigators will deliver a psychoeducational intervention that is manualized over 6 gro...
What is the current status of trial NCT05012072?
This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2021-08-01. Estimated completion is 2026-04-13.
What conditions does trial NCT05012072 study?
This clinical trial studies the following conditions: Preterm Birth, Mental Health Wellness 1.
What interventions are being tested in trial NCT05012072?
The interventions under investigation include: The Mastery Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05012072?
This trial is sponsored by Microgen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05012072 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05012072's enrollment target sits among peer trials
238 18th of 39 higher than 22 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey
RECRUITING · NA
-
Bilateral Infant Stimulation Study
RECRUITING · NA
-
Effect of Support for Low-Income Mothers of Preterm Infants
RECRUITING · NA
-
Sodium Awareness in Lactation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
- NCT06460012 · 238 participants · NA
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI